Bioplasma World Asia 2016 - Hong Kong

Mr. Ahmad Farizal bin Dato’ Abdul Karim, Director,Strovi Tel Sdn Bhd,Malaysia

Mr. Yang Ducai, Technical Director,Jiangxi Boya Bio-pharmaceutical Co. Ltd.,China

Dr. VigneshNarasimhan, CEO,Plasmatech Solutions,India

Dr. Jun Xu, Deputy General Manager,Shanghai RAAS Blood Products Co. Ltd., China

Dr. Ho Jung Oh, Director General,Bio PharmaceuticalPolicy Department, KPMA,Korea

Dr. Yang Renchi, President,NationalHemophiliaCooperative Group,China

Dr. Ivan Hung, Clinical Associate Professor,University of Hong Kong,Hong Kong

Dr. Liu Zhong, Vice President,Institute of Blood Transfusion, CAMS,China

PLASMA PRODUCTS RESEARCH LEADERS

ASIAN PLASMA FRACTIONATORSMr. TsudaMasashige, General Manager of Corporate Strategy Department, JB, Japan

Mr. Yang Hui Chuan, Vice President,China NationalBiotech Group Co.,China

Mr. Jeong Tae Kim, President,SK Plasma,Korea

Dr. Hari Nair, ExecutiveChairman,PrIME Biologics,Singapore

Mr. John E.McCullough, Manager ofInternationalOperations,GenBio SA de CV,Mexico

Ms. KarineStephens, Director,Quality Integration,Shire,USA

Dr. Hamid R. Beheshti, President/Chairman of the Board IBRF,Iran

Dr. Bruno You, Manager,Biosafety Unit,LFB Group,France

Dr. Sami Chtourou, Senior VicePresident Innovation and Scientific Affiars,LFB Biotechnologies,France

Dr. Suma Ray, General Manager,Plasma Operations, Intas Pharma,India

Mr. Eric Youssef, Asian and Europan Plasma Market Director,Merck,France

Dr. Pierre-Francois Falcou, Consultant,PFF Consulting,France

Attendees of international and regional plasma fractionators, blood establishments, national health & regulatory organizations and cold chain and technology providers

150+

25+ Speakers from China, Japan, India, Iran, USA, Europe and more!

10+ Technology exhibitors

20+ Hours of networking

2 Full days of knowledge sharing

19-21 SEPTEMBER 2016HONG KONG

Facilitating the Growth & Innovation of Quality Plasma Products in Asia

Register by

24 June 2016 and

Save USD400

1

Organized & Produced By:

NEW LOCATION - Hong Kong.PLASMA FRACTIONATION TECHNOLOGY WORKSHOP.REGULATOR’S FORUM - meet Global and Asian regulatory experts for plasma and blood products.GLOBAL EMERGING MARKETS Self Sufficiency Case Studies: China, India, Iran and more.INSIGHTS to the first South East Asian plasma fractionation plant.

What is New This

Year?

INTERNATIONAL PLASMA FRACTIONATORS

ADVISORY BOARD

DISTINGUISHED PANEL OF SPEAKERS

W: www.imapac.com/business_conference/bioplasma-world-asia-2016/pricing E: [email protected] C: +65 3109 0129

Sponsor : Industry Partner : Media Partners :

ATTENDEE BREAKDOWN

AGENDA AT A GLANCE

For speaking opportunities, please contact Hazel [email protected] or call +65 3109 0122

Networking Break

Evening Refreshments

Networking Lunch

Day 120 September 2016

Asia’s Progress Update – The Move Towards

Self Sufficiency

Regulatory Landscape Of Developed And Emerging Markets

Challenges And Advances In Plasma Collection And

Biosafety

Manufacturing Best Practices And Excellence

Cocktail Reception

21 September 2016

Day 2

Next GenerationPlasma-Derived

Treatments

PlasmaFractionation Models

In Asia

Global Emerging Markets Self-Sufficiency Case

Studies

New Directions In The Plasma Industry

Conference Ends

Pre-Day Workshop19 September 2016

PlasmaFractionation Technology Workshop

BY INDUSTRY BY LOCATIONBY JOB TITLE

45%

10%

5%

5%

5%

15%

10%

5%

PlasmaFractionatorsBlood Collection CentresTechnologyProvidersDiagnostics &Consumables SuppliesNational Health Organisations

Cold Chain & OthersConsultants, Academics,Research Institute & NGO’sRegulatory Agencies & Government Organization

20%

30%

25%

15%

3%2%

5%

President, CEO’s, VP’s VP’s, Directors, Head of R&DDirectors & Heads of Fractionation/Manufacturing, Viral Clearance, Pathogen Safety

VP’s, Directors, Head of Regulations, QA, QCResearch ScientistsProfessors & AcademicsOthersBusiness Development/Marketing/Sales Heads/Directors & VP’s

South America, Middle East, RussiaSEA & SARest of the World

ChinaKorea and JapanAustraliaUSA & CanadaEurope

2

5%

10%

50%

10%4%

8%

8%

5%

5th Bioplasma World Asia 2016 19-21 September 2016 | Hong Kong


ASIA’S PROGRESS UPDATE - THE MOVE TOWARDS SELF SUFFICIENCY

REGULATORY LANDSCAPE OF DEVELOPED AND EMERGING MARKETS

CHALLENGES AND ADVANCES IN PLASMA COLLECTION AND BIOSAFETY

10:40 Speed Networking

8:00 Registration

IMAPAC welcome remarks8:50

8:55 Chairman’s opening remarks

Conference Day 1 (20 September 2016)

9:00

9:25 Case Study: Business Model Set To Succeed With Small-To-Medium Fractionation Capacity In Emerging Markets

Mr. Jeong Tae Kim, President, SK Plasma, Korea

[Facility vendors with the expertise in the establishment of cost effective plants in Asia]

Insights on operational models and customizable roadmaps for viable small-to-medium fractionation capacity Successful implementation of business/operation strategy in terms of plant construction, product quality management andoperational efficiency in Asia

ASEAN’s first plasma fractionation plant: PrIME Biologics’ Plasma Fractionation Facility in Singapore

Dr. Hari Nair, Executive Chairman, PrIME Biologics, Singapore

The establishment of PrIME biologics as South East Asia’s first plasma fractionation plantDiscussion on the PrIME + system, a unique process where both Cohn fractionation and cryopreciptiation is not used and maximizes Currently Underutilized Plasma (CUP)Novel product innovation focusing on hyper immune therapies and specialty plasma therapeutics

Keynote

Technology Presentation Novel plasma technologies and facilities for the setting up of plasma fractionation plants in Asia 9:50

10:15 Strategies In The Establishment Of A Japanese Fractionation Industry: Insights From JB’s Plasma Derivative Self Sufficiency Project

Mr. Masashige Tsuda, General Manager of Corporate Strategy Department, JB, Japan

Innovations in combining R&D and plasma safety technologies in novel product formulationsStrategies for the production of a safe national supply of plasma productsChallenges and opportunities for Japanese plasma self sufficiency

12:50 Lunch

Panel Discussion12:00 Navigating Asia’s Evolving Quality and Regulatory Trends Of Plasma And Recombinant Products

Moderator: Dr. Alan Liss, Founder, GXP farma, LLC - Consulting, USA Panellists: Ms. Janet Bowen, Vice President QA & QC PrIME Biologics, AustraliaDr. Ho Jung Oh, Director General, Bio Pharmaceutical Policy Department, KPMA, KoreaDr. Bruno You, Manager Biosafety Unit, LFB, France

Differences and similarities between the regulations in Asia and the US and EUInsights on import policies and its impact on self-sufficiency and regulations and licensing of plasma and recombinant products in AsiaImpacts of current regulations and biosafety concerns on Asia’s self sufficiency visionChallenges and opportunities for the harmonization of plasma products in Asia

11:10 Understanding Global Regulatory Landscape & its Impact on the future of the industry: A FDA PerspectiveUpdates on FDA policies on donor screening, selection policies and safety regulations of domestic and imported plasma and recombinant plasma derived productsFactors that could potentially impact plasma regulations in AsiaA closer look at a global lead in the regulation of plasma products and its derivatives

Dr. Alan Liss, Founder, GXP farma, LLC - Consulting, USA

11:35 Overcoming the Regulatory Challenges in the Plasma Industry: Experience and Perspective Of A Leading Asian Regulator

Dr. Ho Jung Oh, Director General, Bio Pharmaceutical Policy Department, KPMA, Korea

13:50 State-Of-The-Art Biosafety Knowledge Of Plasma ProductsEpidemiology of emerging and epidemic viruses affecting blood safetyImplications for plasma safety and regulatory complianceStrategies to ensure pathogen safety in plasma collection and processing

Dr. Bruno You, Manager Biosafety Unit, LFB, France

Which Is A Safer Source Plasma For Manufacturing In China: Apheresis Plasma Or Recovered Plasma?Policy updates and regulations of plasma supplies in ChinaEvaluation of infectious risks for apheresis plasma (AP) and recovered plasma (RP) Strategies for the national implementation of RP supplies and its associated benefits

Dr. Liu Zhong, VP, Institute of Blood Transfusion, CAMS, China

14:40

14:15 Technology Presentation Novel technologies in plasma collection and storage[Equipment vendors with advanced technologies to collect and store plasma]

3


Updates on blood and plasma-derived products regulation in KoreaAn evaluation of plasma-derived products including risks such as viral safetyCritical insight into Korea's position on viral safetyDiscussion & strategies for successful government-industry collaborations


4


Chairman Closing Remarks17:1017:15 Cocktail Reception

MANUFACTURING BEST PRACTICES AND EXCELLENCE

15:30 Cost Reduction Strategies In The Large Scale Manufacturing Of Plasma MedicinesCost cutting methodologies in upgrading and expanding manufacturing pipelines in the large scale production of high quality and safe plasma productsOvercoming the operational and economic challenges in Purifying Highly Complex Coagulated Blood products

Dr. Hamid Ghorbani, Deputy Managing Director & Member of Board, Darman Ara Co., Iran

15:05 Risk Management And Mitigation Strategies In Plasma Collection And FractionationApproaches for risk evaluation and mitigation strategiesChallenges in implementing targeted policies to encourage plasma collectionRegulatory and quality standards for plasma for collection and fractionation

Ms. Karine Stephens, Director, Quality Integration, Shire, USA

15:55 Preparation and Characterization of Activated Prothrombin Complex Concentrate (PCC) from Fraction IIICurrent market trends in the treatment of hemophilia patients with inhibitors in ChinaCutting edge techniques in the isolation, extraction and characterization of PCC from Fraction IIISolvent detergent treatment and nanofiltration method as viral inactivation/removal

Dr Jun Xu, Deputy General Manager, Shanghai RAAS, China

16:45 Strategies For The Development Of A State-Of- The-Art Quality Manufacturing System In AsiaGlobal GMP standards for manufacturing plasma productsCost efficient strategies for the implementation of top GMP standards in AsiaFuture directions in the implementation of quality manufacturing systems in Asia

Ms. Janet Bowen, Vice President QA & QC PrIME Biologics, Australia

16:20 Coagulation Factor Product Development ProcessAn overview of the product development pipelineChallenges and solutions for the development and innovation of highly complex coagulation factorsFuture product development strategies and collaboration projects

Mr Yang Ducai, Technical Director, Jiangxi Boya Bio-phamaceutical Co. Ltd, China


5


NEXT GENERATION PLASMA-DERIVED TREATMENTS

9:35 Efficient and accurate technologies for the detection and treatment of plasma treatments Equipment vendor with technologies for detecting successful plasma treatments

Technology Presentation

9:10 Advances in the treatment of Hemophilia in Mainland ChinaCurrent status of hemophilia care in China Challenges and opportunities in the implementation of hemophilia treatment in ChinaFuture directions in the treatment of Hemophilia in China

Dr. Yang Renchi, President, National Hemophilia Cooperative Group, China

10:00 Treatment of H1N1 Infection With Convalescent Plasma TherapyEfficacy of convalescent plasma therapy in patients with severe pandemic influenza A (H1N1) infectionTreatment methodology and study designFuture directions for plasma therapy of H1N1 infections and other clinical diseases

Dr. Ivan Hung, Clinical Associate Professor and Honorary Consultant in the Department of Medicine, Queen Mary Hospital, University of Hong Kong, Hong Kong

10:25 Medical Procurement Of Plasma Products: What Are The Future Needs In Public Health?Epidemiology of public health needs globally and in AsiaDiscussion of the production, demand & supply and deployment of plasma and recombinant productsFuture healthcare needs and its impacts on industrial players

Dr. Pierre Francois Falcou, Consultant, PFF Consulting, France

Conference Day 2 (21 September 2016)

8:30 Registration

IMAPAC’S welcome remarks9:00

9:05 Chairman’s opening remarks

PLASMA FRACTIONATION MODELS IN ASIA10:50 Networking Break

GLOBAL EMERGING MARKETS SELF SUFFICIENCY CASE STUDIES12:40 Networking Lunch

Dr. Hamid R.Beheshti, President/Chairman of the Board IBRF, Iran

13:40 Plasma Fractionation & Toll Fractionation In Emerging Markets: Promises And ChallengesIran Case Study

Cost effectiveness of an Iran national plasma fractionation programStrategies for the centralization of blood transfusion activities from donor recruitment to production of blood componentsin one organizationCost benefit analysis of contract vs national fractionation

11:25 The Chengdu Rongsheng Fractionation Model: Perspectives From A Top Chinese FractionatorStrategies for the modernization of existing technologiesStrategies for facility and technology selection for optimal fractionation capacity Future plans for national and international expansion

Mr. Yang Hui Chuan, Vice President, China National Biotech Group Co, China

Strategies & Perspectives For Novel Product Innovation In ChinaAn overview of the design, characteristics and process of plasma product developmentChallenges and Solutions for the implementation of new technologiesTechnical administration and patent registration, clinical trials and management practices in product development

Mr. Pang Guangli, General Manager, Shandong Taibang Biological Products Co. Ltd, China

12:15

11:50 Modular Plasma Fractionation In India: Possibilities Of Achieving Plasma Product Self SufficiencyOverview on technological advances and new players in the Indian Plasma IndustryStrategies for the development of indigenous processes for cost effective nationwide implementation Public-Private collaborations for self-sufficiency in India

Dr. Vignesh Narasimhan Janakiraman, CEO, Plasmatech Solutions, India

14:05 Updates On Ukraine’s First & Only Greenfield Pharmaceutical PlantPast and present trends in the Ukrainian plasma marketPlasma product innovations and novel clinical applications for existing plasma productsStrategies for top quality production at an affordable costFuture collaboration and market entry strategies in Asia and beyond



6

NEW DIRECTIONS IN THE PLASMA INDUSTRY14:55 Evening Refreshments

Mr. John E. McCullough, Manager of International Operations, GenBio SA de CV, Mexico

14:30 A Market Based Solution to Developing Fractionation Capacity in South AmericaOverview of world market for plasma products with a concentration in South America and AsiaChallenges and strategies for the establishment of a South American plant that could be implementable to AsiaGenBio facility: Discussion of products, technology and the way forward, including future expansion plans

Chairman Closing Remarks16:3516:40 Cocktail Reception

15:45 Navigating Future Trends And Asia’s Rise In The Global Plasma IndustryThe search for direction and a regional and global Asian leadership Biggest Challenges in setting up an Asian fractionation plant and modular approaches around it Challenges and opportunities in the adoption of recombinant technologies in AsiaThe implications of partnerships and acquisitions and the emergence of new players on the Asian plasma industryMarket forecast: On-going key market and technology trends and anticipated growth in the next 5-10 years in Asia

Panel Discussion

Moderator: Dr. Pierre Francois Falcou, Consultant, PFF Consulting

Panellists:Dr Jun Xu, Deputy General Manager, Shanghai RAAS, ChinaDr. Hari Nair, Executive Chairman, PrIME Biologics, SingaporeMr. Ahmad Farizal bin Dato’ Abdul Karim, Director, Strove Tel Sdn Bhd, Malaysia

15:20 Self-Sufficiency In Malaysia: Challenges & OpportunitiesOverview of plasma economics, policies and regulations in MalaysiaStrategies towards Self-Sufficiency through collaborations and innovative technologiesFuture outlook and fractionation plans for Malaysia

Mr. Ahmad Farizal bin Dato’ Abdul Karim, Director, Strovi Tel Sdn Bhd, Malaysia


MARKETING & SALES OPPORTUNITIES

5TH BIOPLASMA WORLD ASIA 2016

Exhibition opportunityTechnology showcaseMaterial distribution during the eventConducting a workshop, and more!

EDUCATING THE MARKET:

NETWORKING AND LEAD GENERATION

Exhibition opportunityCocktail sponsorshipLunch sponsorshipTea break sponsorshipExtra delegate passesExhibition passesClient passesPrivate one-one meetings, & more!

For sponsorship & exhibition opportunities, please contact:

Ana LaxamanaRegional BusinessDevelopment DirectorWork: +65 3109 [email protected]

Conference chairmanshipSpeaking opportunityModerating a panelFacilitating a Q&A sessionPresenting a client case study…and more!

THOUGHT LEADERSHIP:

BRANDING:

Logo presence on printed brochure,internally generated content, e-brochure, E-mail blasts, conference website,partner websites, and more!

Pre-conference

Logo on conference back-drop, on-screen presentations, conferencebooklet, material distribution, logopresence on select material, & more! Company mention before and afterthe conference.

On-site

World-class solution providers who need to position their products and services in front of decision makers from major fractionators

and plasma protein manufacturers.

No other Bioplasma event can get you one-to-one access to senior decision-makers from both theinternational and regional Bioplasma industry.

Make sure you get access to Asia’s growing Bioplasma and blood derived products market and aren’tmissing out this opportunity. See a real ROI by being part of Asia’s Bioplasma industry’s most compre-hensive marketing campaign. So to showcase your latest innovation in chromatography, filtration and separation techniques, do not miss this EXCEPTIONAL OPPORTUNITY to display them before the World’s top Bioplasma executives.

Filtration Equipment providersAnalytical instrument manufacturersAnalytical testing service providersTechnology platforms for fractionationAutomation systems and softwareProcess control solution providersSmart lab design solution providersGreen technology providersLaw firmsConsultantsDistribution and logisticsCold chain storagePackagingRegional development agenciesBiotechsVenture capitalists

WHO SHOULD SPONSOR?

7



YOUR DETAILS

NameJob TitleAddressPostcodeTelEmailYour primary businessAuthorising Manager

By signing and returning this form, you are accepting our terms and conditions.

Organizaton

CountryFax

Authorising manager signature

REGISTRATION FORM

4 Easy Ways to Register:

EVENT VENUE

Group Booking

19-21 September 2016Hong Kong

OnlineThe quickest & easiest way toregister is online using a creditcard. Visit: http://www.imapac.com/business_conference/bioplasma-world-asia-2016/pricing

By FaxPlease fax your booking form to +65 6270 2792

MailBy cheque made payable to: IMAPAC PTE. LTD.

Send with this booking form to:IMAPAC PTE. LTD.133 Cecil Street #05-02AKeck Seng TowerSingapore 069535

Send your team & save more!3 delegates5 delegates

Save 10%

Save 20%

Full payment is due upon registration if you pay by credit card, or 3 working days after receipt of invoice.Registration will not be confirmed until full payment has been received.Unpaid registration will be billed 50% of the registration fee if you do not attend the event. A copy of the conference documentation will be mailed to you.The registration fee includes refreshments, lunches, cocktails and full conference documentation. The conference fee does not include hotel accomodation.Staff at the event will request a credit card guarantee for delegates without proof of payment.

TERMS & CONDITIONS:

CANCELLATION & SUBSTITUTION POLICY:Cancellations must be received in writing. If the cancellation is received more than 14 days before the conference attendees will receive a full credit note to a future conference. Cancellationsreceived 14 days or less (including the fourteenth day) prior to the conference will be liable for the full fee.A substitution from the same organisation can be made at any time in writing at no extra charge.In the event that IMAPAC cancels a conference, payments received at the cancellation date will be credited towards attendance at a future conference or in the event of postponement by IMAPAC,towards the rescheduled date.Credit notes remain valid for twelve months.

CHANGES TO CONFERENCE & AGENDA: IMAPAC reserves the right to postpone or cancel an event, to change the location or alter the advertised speakers for an event. IMAPAC is not responsible for any lossor damage as a result of substitution, alteration, postponement or cancellation of an event due to causes beyond its control including without limitation, acts of God, natural disasters, sabotage, accident, trade orindustrial disputes, terrorism or hostilities.

In the event that a conference is cancelled, IMAPAC is not liable for any costs incurred by delegates in connection with their attendance. Control to alter the content and timing of the programme,venue or the identity of the speakers without any liability to the delegates. Changes to the agenda will be updated on our website as soon as possible.

DATA PROTECTION: The personal information shown and/or provided by you will be held in a database. It may be used to keep you up to date with developments in your industry. Sometimes yourdetails may be obtained or made available to reputable third parties for marketing purposes. If you do not wish your details to be used for this purpose, please write to: [email protected].

PAYMENT DETAILS

Payment is due immediately upon receipt of this registration form if you pay by credit card or 3 working days afteryour receipt of payment notification. Non-credit card payment will incur an additional US$100

I want to pay Credit Card Non-credit card and add US$100 booking fee

Offline credit card payment: Visa MasterCard American Express

Name on CardExpiry Date

Card NumberSignature

Bank transfer: Payment by bank transfer must quote delegate name and conference name.For bank details & swift code, it will be emailed to you as part of the invoice. Cheque payment: Crossed cheque payable to IMAPAC Pte Ltd, and mail it in a sealed envelopeto IMAPAC Pte Ltd, 133 Cecil Street #05-02A Keck Seng Tower Singapore 069535

LIMITEDSPECIAL

(By 27 May 2016)

LIMITED SUPER

(By 24 June 2016)

EARLY BIRD

(By 5 Aug 2016)

STANDARD RATE

USD 129 USD 139 USD 149 USD 1592-Day Conference Pass Buy 2 Get 3 Buy 3 Get 5

Government, Health Professionals, NGOs & Academics

Fractionators

Solution Providers & Others

Patients

USD 2,395 USD 2,595 USD 2,795 USD 2,9953-Day Conference Pass Buy 2 Get 3 Buy 3 Get 5

USD 799 USD 899 USD 999 USD 1,0993-Day Conference Pass Buy 2 Get 3 Buy 3 Get 5

USD 3,195 USD 3,395 USD 3,595 USD 3,7953-Day Conference Pass

USD 1,695 USD 1,895 USD 2,095 USD 2,2952-Day Conference Pass Buy 2 Get 3 Buy 3 Get 5

USD 599 USD 699 USD 799 USD 8992-Day Conference Pass Buy 2 Get 3 Buy 3 Get 5

USD 2,395 USD 2,595 USD 2,795 USD 2,9952-Day Conference Pass

USD 1,095 USD 1,295 USD 1,495 USD 1,695

USD 399 USD 499 USD 599 USD 699

USD 1,495 USD 1,695 USD 1,895 USD 2,095

1-Day Fractionation Technology Workshop



Limited to 1st 10organizations

only. (1st come 1st served)





8



Call +65 3109 0129 or go online& register at: http://www.imapac.com/business_conference/bioplasma-world-asia-2016/pricing

TelephoneTo register over the phone, pleasecall us on +65 3109 0129

The registration fee includes refreshments, lunch and full conference documentation.The conference fee does not include hotel accomodation. Special discounts and eligibility (Only one discount scheme is applicable):ACADEMIC DISCOUNT Academics, NGOs, government & non-profit representatives enjoy up to 40% off the usual conference pricing.INNERCIRCLE Speaker referrals & professionals working in the same organization as our speakers are entitled to a 15% discount.PRICE FREEZE Clients of our sponsors & exhibitors can avail the first-tier price throughout the campaign, even after the deadline has passed! GROUP PACKAGES Save 10% for 3 delegates & 20% for 5 delegates.To confirm your eligibility for special discount, please contact Justin at [email protected] for more details.

Healthcare

Bioplasma World Asia 2016 - Hong Kong